16
Participants
Start Date
September 24, 2024
Primary Completion Date
November 25, 2025
Study Completion Date
November 25, 2025
ARGX-119
Intravenous infusion of ARGX-119
Placebo
Intravenous infusion of placebo
CHU - Hospital de la Timone, Marseille
Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan
Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur), Valencia
Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago
Group Hospitalier Pitie-Salpetriere, Paris
UC Davis Medical Center, Sacramento
Ottawa Hospital Research Institute - Civic Campus, Ottawa
Clinical Trials Centre - South Eastern Health and Social Care Trust - The Ulster Hospital, Belfast
John Radcliffe Hospital - Oxford University Hospitals NHS Foundation Trust, Oxford
Lead Sponsor
argenx
INDUSTRY